All News

People Share Tips on How They Have Dealt With Cancer-Related Fatigue

March 8th 2021, 10:00pm


On social media, CURE® recently asked its readers to share if they have experienced cancer-related fatigue and how they have dealt with it.

7 Recent Updates in the Field of Women's Cancers

March 8th 2021, 7:00pm


In honor of International Women’s Day, CURE® compiled some recent news and updates in women’s cancers that patients, survivors and caregivers may have missed.

Why My ‘Normal’ Breast Now Feels Like a Liability

March 8th 2021, 5:00pm


A breast cancer survivor who opted for a bilateral mastectomy advises people to look at all treatment and risk reduction options when first diagnosed with breast cancer so they can avoid any regrets years later.

Death From Heart-Related Causes May Affect Cancer Survivors More Than the General Population

March 8th 2021, 4:00pm


More than half of the deaths assessed in this study were related to non-cancer-related causes such as cardiovascular disease compared with cancer-related causes, which may reflect a need for risk factor management for heart disease during survivorship.

7 Recent News and Updates in Lung Cancer

March 8th 2021, 2:00pm


A roundup of some of the latest news and updates for patients with lung cancer from CURE®.

The Problem With the Phrase ‘Cancer-Free’

March 7th 2021, 7:00pm


A survivor takes a closer look at the trouble with using the phrase “cancer-free” when discussing the disease with friends and family.

Recent Colon Cancer News and Updates Patients and Survivors May Have Missed

March 7th 2021, 4:00pm


In honor of Colorectal Cancer Awareness Month, CURE® compiled some recent colorectal cancer news and updates patients and survivors may have missed.

Why I’m Forever Grateful for My Genetic Mutations

March 6th 2021, 7:00pm


As her seven-year cancerversary approaches, one patient with metastatic breast cancer shares why she is grateful to be a 'mutant'.

Recent Breast Cancer News and Updates Patients May Have Missed

March 6th 2021, 4:00pm


A roundup of some of the latest news and updates for patients with breast cancer from CURE®

FDA Approves Yescarta for Third-Line Treatment of Relapsed or Refractory Follicular Lymphoma

March 6th 2021, 2:06am


This accelerated FDA approval is the first CAR T-cell therapy approved for the treatment of patients with indolent follicular lymphoma.